Biomarker: F233-IgE Ovomucoid

Overview

F233-IgE Ovomucoid measures serum immunoglobulin E (IgE) antibodies directed against ovomucoid, also known as Gal d 1, a major glycoprotein allergen in hen’s egg white. Ovomucoid has trypsin-inhibitor activity and is relatively resistant to heat and digestion, which may contribute to reactions to cooked or baked egg. Elevated ovomucoid-specific IgE indicates sensitization but does not independently confirm clinical egg allergy or predict reaction severity. The test is clinically useful as part of an allergist’s evaluation, particularly when assessing persistent egg allergy or the likelihood of reacting to heated egg, although egg-white-specific IgE and supervised oral food challenge may provide additional or more definitive information.

Clinical Use Cases

Supporting evaluation of suspected IgE-mediated hen’s egg allergy.
Assessing sensitization to ovomucoid as part of component-resolved allergy testing.
Estimating the likelihood of reacting to cooked or heated egg in selected patients.
Supporting assessment of persistent egg allergy, particularly when interpreted with clinical history and other allergy tests.
Helping allergists select or interpret patients for a medically supervised oral food challenge.
Monitoring ovomucoid-specific IgE trends during clinical follow-up or research; changes should not be interpreted alone as proof of developing tolerance.

Specimen Types

Venous blood, typically collected as serum.
Plasma may be accepted by some laboratory methods, depending on the assay protocol.

Measurement Methods

Fluorescence enzyme immunoassay or other automated quantitative allergen-specific IgE immunoassay.
Enzyme-linked immunosorbent assay-based methods in research settings.
Immunoassay-based component-resolved testing using purified or recombinant ovomucoid.
Historical radioallergosorbent test methods have been used in research but are less common in current clinical practice.

Test Preparation and Influencing Factors

Fasting is generally not required for an allergy blood test.
Patients should report all prescription medicines, over-the-counter medicines, and supplements. Medications should not be stopped unless instructed by a health care professional.
Antihistamines generally do not alter serum-specific IgE measurement, although they may affect skin-prick testing. The testing clinician should provide medication-specific instructions.
Results should be interpreted with the patient’s reaction history, age, diet, other egg-specific IgE results, and clinical examination.
A positive result indicates sensitization and does not by itself establish symptomatic allergy or predict reaction severity.
Ovomucoid-specific IgE concentrations and clinical decision points vary by population, assay, age, and egg preparation. Published thresholds should not be transferred between assays without clinical validation.
A negative or low result does not completely exclude egg allergy, especially when the clinical history is strongly suggestive.
Oral food challenges, when needed, must be performed under medical supervision because allergic reactions can be severe.